IFNA1 and systemic lupus erythematosus: In autoimmune diseases, ISGs have drawn interest for their ability to define a transcriptome signature that is used to indirectly evaluate the degree of IFN-mediated inflammation in conditions such as Sjogren’s disease, dermatomyositis, and SLE.